Trial NCT03267940

View at ClinicalTrials.gov 
Org. Study IDs: Halo-110-101

Last trial update was posted on 2020-02-07

MeSH Interventions

Atezolizumab

MeSH Conditions

Adenocarcinoma Cholangiocarcinoma

Other Conditions

Cholangiocarcinoma Non-resectable Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, Intrahepatic Gallbladder Adenocarcinoma

Stopping Reasons

Sponsor decision

Limitations And Caveats

The study was terminated prematurely by the Sponsor due to stopping the clinical development of PEGPH20 in all indications based on negative pivotal data in metastatic pancreatic cancer.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID